An Absorption, Distribution, Metabolism and Excretion (ADME) Study of Single Oral Dose [14C] GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Clinical trial NCT01262963 · COMPLETED
Trial details
- NCT number
- NCT01262963
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-26
- Primary completion
- 2011-04-08
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.